Literature DB >> 16847131

Infectivity variation and genetic diversity among strains of Western equine encephalitis virus.

Les P Nagata1, Wei-Gang Hu, Michael Parker, Damon Chau, George A Rayner, Fay L Schmaltz, Jonathan P Wong.   

Abstract

Variation in infectivity and genetic diversity in the structural proteins were compared among eight strains of Western equine encephalitis virus (WEEV) to investigate WEEV virulence at the molecular level. A lethal intranasal infectivity model of WEEV was developed in adult BALB/c mice. All eight strains examined were 100 % lethal to adult mice in this model, but they varied considerably in the time to death. Based on the time to death, the eight strains could be classified into two pathotypes: a high-virulence pathotype, consisting of strains California, Fleming and McMillan, and a low-virulence pathotype, comprising strains CBA87, Mn548, B11, Mn520 and 71V-1658. To analyse genetic diversity in the structural protein genes, 26S RNAs from these eight strains were cloned and sequenced and found to have > 96 % nucleotide and amino acid identity. A cluster diagram divided the eight WEEV strains into two genotypes that matched the pathotype grouping exactly, suggesting that variation in infectivity can be attributed to genetic diversity in the structural proteins among these eight strains. Furthermore, potential amino acid differences in some positions between the two groups were identified, suggesting that these amino acid variations contributed to the observed differences in virulence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847131     DOI: 10.1099/vir.0.81815-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

1.  Manipulation of host factors optimizes the pathogenesis of western equine encephalitis virus infections in mice for antiviral drug development.

Authors:  Pennelope K Blakely; Phillip C Delekta; David J Miller; David N Irani
Journal:  J Neurovirol       Date:  2014-11-01       Impact factor: 2.643

2.  Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model.

Authors:  Justin G Julander; Venkatraman Siddharthan; Lawrence M Blatt; Kristiina Schafer; Robert W Sidwell; John D Morrey
Journal:  Virology       Date:  2006-11-21       Impact factor: 3.616

3.  Western Equine Encephalitis submergence: lack of evidence for a decline in virus virulence.

Authors:  Naomi L Forrester; Joan L Kenney; Eleanor Deardorff; Eryu Wang; Scott C Weaver
Journal:  Virology       Date:  2008-09-17       Impact factor: 3.616

4.  Current strategic thinking for the development of a trivalent alphavirus vaccine for human use.

Authors:  Daniel N Wolfe; D Gray Heppner; Shea N Gardner; Crystal Jaing; Lesley C Dupuy; Connie S Schmaljohn; Kevin Carlton
Journal:  Am J Trop Med Hyg       Date:  2014-05-19       Impact factor: 2.345

5.  Chimeric alphavirus vaccine candidates protect mice from intranasal challenge with western equine encephalitis virus.

Authors:  Svetlana Atasheva; Eryu Wang; A Paige Adams; Kenneth S Plante; Sai Ni; Katherine Taylor; Mary E Miller; Ilya Frolov; Scott C Weaver
Journal:  Vaccine       Date:  2009-05-27       Impact factor: 3.641

6.  Identification of Western equine encephalitis virus structural proteins that confer protection after DNA vaccination.

Authors:  Penelope J Gauci; Josh Q H Wu; George A Rayner; Nicole D Barabé; Leslie P Nagata; David F Proll
Journal:  Clin Vaccine Immunol       Date:  2009-11-18

7.  Virulence variation among isolates of western equine encephalitis virus in an outbred mouse model.

Authors:  Christopher H Logue; Christopher F Bosio; Thomas Welte; Kimberley M Keene; Jeremy P Ledermann; Aaron Phillips; Brian J Sheahan; Dennis J Pierro; Nicole Marlenee; Aaron C Brault; Catharine M Bosio; Amber J Singh; Ann M Powers; Ken E Olson
Journal:  J Gen Virol       Date:  2009-04-29       Impact factor: 3.891

8.  Western equine encephalitis virus: evolutionary analysis of a declining alphavirus based on complete genome sequences.

Authors:  Nicholas A Bergren; Albert J Auguste; Naomi L Forrester; Surendra S Negi; Werner A Braun; Scott C Weaver
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

9.  Deficiency of the IRE1α-Autophagy Axis Enhances the Antitumor Effects of the Oncolytic Virus M1.

Authors:  Kai Li; Cheng Hu; Fan Xing; Mingshi Gao; Jiankai Liang; Xiao Xiao; Jing Cai; Yaqian Tan; Jun Hu; Wenbo Zhu; Wei Yin; Yuan Li; Wenli Chen; Bingzheng Lu; Jialuo Mai; Pengxin Qiu; Xingwen Su; Guangmei Yan; Haipeng Zhang; Yuan Lin
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

10.  Molecular determinants of mouse neurovirulence and mosquito infection for Western equine encephalitis virus.

Authors:  Eric C Mossel; Jeremy P Ledermann; Aaron T Phillips; Erin M Borland; Ann M Powers; Ken E Olson
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.